Other Clinical Trial - Safety, Tolerability, & Efficacy of Encaleret in

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02204579` - A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations	Phase 2
	Recruiting	`NCT05680818` - Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1	Phase 3

See also

Status

Clinical Trial

Phase

Completed

NCT02204579 - A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations

Phase 2

Recruiting

NCT05680818 - Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04581629
Study type	Interventional
Source	Calcilytix Therapeutics, Inc., a BridgeBio company
Contact
Status	Completed
Phase	Phase 2
Start date	September 15, 2020
Completion date	September 7, 2023

Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms